Cornelia Coith
Overview
Explore the profile of Cornelia Coith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pouyiourou M, Bochtler T, Coith C, Wikman H, Kraft B, Hielscher T, et al.
Clin Chem
. 2024 Jan;
70(1):297-306.
PMID: 38175594
Background: Cancer of unknown primary (CUP) is defined as a primary metastatic malignancy, in which the primary tumor remains elusive in spite of a comprehensive diagnostic workup. The frequency and...
2.
Paschold L, Stein A, Thiele B, Tintelnot J, Henkes S, Coith C, et al.
J Immunother Cancer
. 2023 Jun;
11(6).
PMID: 37328285
Background: The addition of nivolumab to trastuzumab and chemotherapy in first-line unresectable or metastatic HER2 positive esophagogastric adenocarcinoma (HER2+ EGA) results in long progression-free and overall survival as shown by...
3.
Derlin T, Riethdorf S, Schumacher U, Lafos M, Peine S, Coith C, et al.
Prostate
. 2023 May;
83(11):1076-1088.
PMID: 37147881
Background: We explored the interrelation between prostate-specific membrane antigen (PSMA) expression on circulating tumor cells (CTCs) and that of solid metastatic lesions as determined by whole-body PSMA-targeted positron emission tomography...
4.
Bergmann S, Coym A, Ott L, Soave A, Rink M, Janning M, et al.
Oncoimmunology
. 2020 May;
9(1):1738798.
PMID: 32391189
Immune checkpoint inhibition (ICI) of the PD-1/PD-L1 axis shows durable responses in a subset of patients with metastatic urothelial carcinoma (UC). However, PD-L1 expression in tumor biopsies does not necessarily...
5.
Riethdorf S, Hildebrandt L, Heinzerling L, Heitzer E, Fischer N, Bergmann S, et al.
Clin Chem
. 2019 Jan;
65(3):462-472.
PMID: 30626636
Background: Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer with increasing incidence and high mortality rates. MCC has recently become the subject of immune checkpoint therapy, but reliable...
6.
Gasch C, Oldopp T, Mauermann O, Gorges T, Andreas A, Coith C, et al.
Mol Oncol
. 2016 Aug;
10(8):1330-43.
PMID: 27491860
Modern technologies enable detection and characterization of circulating tumor cells (CTC) in peripheral blood samples. Thus, CTC have attracted interest as markers for therapeutic response in breast cancer. First studies...
7.
Rink M, Chun F, Dahlem R, Soave A, Minner S, Hansen J, et al.
Eur Urol
. 2012 Jan;
61(4):810-7.
PMID: 22277196
Background: Preliminary research has suggested the potential prognostic value of circulating tumor cells (CTC) in patients with advanced nonmetastatic urothelial carcinoma of the bladder (UCB). Objective: Prospectively analyze the clinical...
8.
Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, et al.
Clin Cancer Res
. 2007 Feb;
13(3):920-8.
PMID: 17289886
Purpose: The CellSearch system (Veridex, Warren, NJ) is designed to enrich and enumerate circulating tumor cells (CTCs) from peripheral blood. Here, we validated the analytic performance of this system for...
9.
Thurm H, Ebel S, Kentenich C, Hemsen A, Riethdorf S, Coith C, et al.
Clin Cancer Res
. 2003 Jul;
9(7):2598-604.
PMID: 12855636
Purpose: Over the past 5 years, several clinical studies on a total of approximately 2500 patients have shown that the immunocytochemical detection of occult metastatic tumor cells in bone marrow...